1.17. Analysis.
Comparison 1 Surgery versus non‐surgery, Outcome 17 Comorbitidies: Lipids.
| Comorbitidies: Lipids | ||||
|---|---|---|---|---|
| Study | Outcome | Surgery | No surgery | P value |
| Dixon 2008 | Lipid lowering agents at baseline, n/N (%) | 12/29 (41.4%) | 8/26 (30.8%) | |
| Dixon 2008 | Lipid lowering agents at 2‐years, n/N (%) | 4/29 (13.8%) | 7/26 (26.9%) | |
| Dixon 2008 | ||||
| Ikramuddin 2013 | % with LDL cholesterol < 100 mg/dl at 12 months, n (%) | 45 (79) | 38 (70) | OR 1.6 (95% CI 0.7 to 3.8) |
| Ikramuddin 2013 | ||||
| Ikramuddin 2013 | ||||
| Mingrone 2012 | Total cholesterol normalisation at 2 years, % | 100 | 27.3 | P < 0.001 |
| Mingrone 2012 | HDL cholesterol normalisation at 2 years, % | 100 | 11.1 | P < 0.005 |
| Mingrone 2012 | Triglyceride normalisation at 2 years, % | 85.7 | 0 | P < 0.001 |